Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Curosurf 240mg Injection
Manufacturer/Marketed By : PAVIOUR PHARMACEUTICALS PVT LTD
$215.67 $202.74
Curosurf 240mg injection contains active components such as Poractant alfa. It is a lung surfactant medication used to treat Respiratory Distress Syndrome (RDS) in premature infants. It is a lifesaving...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
PORACTANT ALFA
Active Pharmaceutical Ingredient
Curosurf 240mg Injection
215.67$
202.74$
Curosurf 240mg injection contains active components such as Poractant alfa. It is a lung surfactant medication used to treat Respiratory Distress Syndrome (RDS) in premature infants. It is a lifesaving medication that has improved the survival and outcomes of many premature infants. It has been shown to reduce the risk of death, the need for mechanical ventilation, and the length of hospital stay in premature infants with RDS. It is a good option for infants who are at risk for developing bronchopulmonary dysplasia (BPD), a chronic lung disease that can develop in premature infants. It is more stable than other surfactant medications, which means it can be stored longer without losing effectiveness. If someone is hypersensitive to Curosurf 240mg injection, they should not receive the medication. They may experience a severe allergic reaction, such as anaphylaxis. It should not be used for infants with severe RDS. This is because the medication may not be effective in these infants. This medication should not be given to infants with a history of porcine protein hypersensitivity. This medication can increase the risk of bleeding. Therefore, it should not be given to infants with active bleeding. It may not be effective in infants with neonatal pneumonia and meconium aspiration syndrome. Curosurf 240mg injection is not used in old age because it is ineffective in adults.
Active Pharmaceutical Ingredient
Uses
• Respiratory distress syndrome (RDS)
Benefits
Curosurf 240mg injection lowers the surface tension in the lungs by forming a film on the surface of the alveoli, the tiny air sacs in the lungs. This film reduces the force of attraction between the water molecules in the alveoli, making it easier for them to stay open.
Side Effects
Curosurf 240mg injection causes some side effects like all medications, although not everyone will experience them.
Most Common Side Effects
• Bradycardia
• Hypotension
• Hypoxemia (decreased oxygen)
• Respiratory distress
• Apnea
• Froth at the mouth
• Irritation at the injection site
Common Side Effects
• Anaphylaxis
• Bleeding
• Pulmonary hemorrhage
• Intracranial hemorrhage
• Surfactant protein B deficiency
How To Use
Curosurf 240mg injection is administered through a breathing tube into the infant's lungs. This is called endotracheopulmonary administration. It is a relatively simple procedure that can be done in a hospital setting.
Safety Advice
• Breast Feeding: Curosurf 240mg injection's safety during breastfeeding is not well established. Consult a healthcare provider before using this medication while breastfeeding.
• Alcohol: It is unsafe to take Curosurf 240mg injection with alcohol as it can increase the risk of bleeding and other complications.
• Liver: Individuals with liver disease should consult a doctor regarding the use of Curosurf 240mg injection.
• Lungs: If you have lung conditions, it is advisable to consult your healthcare provider before Curosurf 240mg injection
• Driving: Driving is unsafe after receiving Curosurf 240mg injection as it can cause drowsiness and dizziness.
• Pregnancy: If it is always better to consult a doctor before using Curosurf 240mg injection if you are pregnant or planning to become pregnant.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.